Does Metformin Cause Frequent Urination?

Metformin is not a recognized cause of frequent urination. It does not appear on standard lists of urinary side effects for the drug, and emerging research suggests it may actually help the body concentrate urine and reduce certain lower urinary tract symptoms over time. The confusion is understandable, though, because the condition metformin treats (type 2 diabetes) is itself a classic cause of excessive urination, and metformin is frequently prescribed alongside other diabetes medications that genuinely do increase how often you go.

Why Diabetes Itself Is Usually the Culprit

When blood sugar runs high, the kidneys cannot reabsorb all the excess glucose, so it spills into the urine and drags extra water along with it. This process, called osmotic diuresis, is one of the most recognizable symptoms of poorly controlled diabetes. People who have just been diagnosed with type 2 diabetes and started on metformin sometimes notice they are urinating frequently and assume the new pill is responsible. In most cases, it is the disease they are treating, not the treatment.

As metformin lowers blood sugar over weeks and months, that glucose-driven water loss should ease. If frequent urination persists even after blood sugar levels improve, it is worth investigating other explanations rather than pointing to metformin. A review of metformin’s therapeutic profile in type 2 diabetes identifies gastrointestinal complaints like nausea, diarrhea, and abdominal discomfort as the drug’s dominant side effects, with urinary symptoms not among them.

Metformin May Help the Kidneys Hold Onto Water

Rather than pushing more water into the bladder, metformin appears to do the opposite at the molecular level. Studies in rodents have shown that metformin activates an enzyme called AMPK in the kidney’s inner collecting ducts, which in turn increases the activity of aquaporin 2, a water channel protein. When aquaporin 2 accumulates on the surface of kidney cells, water moves back into the body instead of being lost in urine. In rats treated with a drug that blocks the kidney’s normal water-retention signaling, metformin restored urine concentration to near-normal levels within three days, and the effect lasted at least ten days.¹

A separate set of experiments confirmed that metformin increased both water permeability and urea permeability in perfused kidney tubules from rats, and it boosted urine concentration in mice that genetically lack a key receptor used in normal water balance.² These are animal studies, so translating them directly to people requires caution. But the direction of the evidence is consistent: metformin’s effect on the kidney, if anything, favors concentrating urine rather than producing more of it.

Human data, while limited, points the same way. A retrospective analysis of patients with both diabetes and kidney stones found that urine volume showed only a very small increase after starting metformin, going from about 2.1 to 2.2 liters per day. That difference was statistically detectable but clinically minor, and would not translate into a noticeable change in how often someone needs to use the bathroom.³

Long-Term Metformin Use and Lower Urinary Tract Symptoms

The strongest human evidence on this question comes from a large Taiwanese cohort study of men with type 2 diabetes. Researchers tracked over 45,000 metformin users and a similar number of non-users to see who developed lower urinary tract symptoms, a category that includes frequent urination, urgency, weak stream, and nighttime bathroom trips. Men who used metformin had roughly a 30% lower risk of developing these symptoms compared to those who never used it. The protective association grew stronger the longer men took the drug and the higher their cumulative dose: those in the highest duration quartile (more than about five and a half years of use) had a 60% lower risk.⁴

This is an observational study rather than a randomized trial, so there could be other explanations for the association. Men who took metformin consistently may have been generally healthier or better about managing their diabetes. Still, the dose-response pattern, where more metformin correlated with progressively fewer symptoms, strengthens the case that metformin itself plays a role rather than just serving as a marker for healthier patients.

What Metformin Does to Bladder Muscle

Part of the explanation for metformin’s potential urinary benefits may lie in its effects on the bladder wall itself. In a rat study examining diabetic bladder dysfunction, exposure to methylglyoxal (a toxic byproduct that accumulates when blood sugar is chronically high) caused the bladder to contract more forcefully and erratically. Metformin treatment reversed those changes, normalizing both the bladder contractions and the structural damage to the bladder lining.⁵ The implication is that metformin may protect the bladder from the kind of dysfunction that diabetes causes over time, helping it function normally rather than triggering overactivity.

Another animal study found that in ovariectomized rats (a model used to mimic postmenopausal hormone changes), metformin partially restored the bladder muscle’s weakened ability to contract in response to signals. This raises the possibility that metformin could help maintain healthy bladder tone in some situations.⁶

A separate experiment looking at isolated rat bladder tissue found that applying metformin directly increased the strength of contractions in a dose-dependent manner. At high concentrations, the increase was quite pronounced.⁷ These findings are preliminary and based on lab conditions rather than living human bladders, but they add to the picture of metformin as a drug that, if anything, supports rather than undermines bladder function.

The SGLT-2 Inhibitor Mix-Up

One very common source of confusion involves a newer class of diabetes drugs called SGLT-2 inhibitors. Medications like empagliflozin, dapagliflozin, and canagliflozin work by blocking glucose reabsorption in the kidneys, which means the excess glucose leaves the body through urine and takes water with it. These drugs genuinely do increase urine production and frequency. They also raise the risk of urinary tract infections and genital fungal infections because the sugar-rich urine creates a friendlier environment for microbes.

Metformin is frequently prescribed alongside SGLT-2 inhibitors, and many combination pills contain both drugs in a single tablet. If you start a combination and notice more frequent trips to the bathroom, the SGLT-2 component is the likely cause. An analysis of FDA adverse event reports found that when SGLT-2 inhibitors were combined with metformin, the rate of urinary tract infections was actually lower than with SGLT-2 inhibitors alone, and fungal infections dropped significantly as well.⁸ In other words, metformin may partially offset the urinary side effects of the drugs it is commonly paired with.

Does Metformin Raise the Risk of Urinary Tract Infections?

Urinary tract infections can produce symptoms that feel a lot like frequent urination: urgency, burning, and the sensation that you need to go even when your bladder is nearly empty. People with diabetes already face a higher UTI risk than the general population, so it is reasonable to wonder whether metformin adds to that risk. A large cohort study that adjusted for other factors found no significant difference in the risk of developing a UTI between metformin users and non-users with type 2 diabetes. The adjusted hazard ratio was 1.06, meaning essentially no meaningful change in risk. Recurrent UTI risk was similarly unchanged. Interestingly, though, metformin users who did develop a UTI or sepsis had a substantially lower risk of dying from it.⁹

So metformin does not appear to be making UTIs more likely. If you develop UTI symptoms while taking metformin, the diabetes itself and other factors (catheter use, kidney function, blood sugar control) are more plausible explanations than the medication.

Nighttime Urination and Glycemic Control

Nocturia, the need to get up and urinate during the night, is one of the most disruptive urinary complaints among older adults with type 2 diabetes. A narrative review examining metformin’s effects on sleep in older adults identified four pathways through which the drug might actually reduce nighttime urination: it stabilizes blood sugar (which reduces the osmotic diuresis that drives nighttime trips), it dampens neuroinflammation through AMPK activation, it influences the body’s circadian clock gene expression, and it may protect the neural circuits that regulate sleep.¹⁰ This is a theoretical framework rather than a clinical trial result, but it aligns with the other evidence suggesting metformin helps urinary symptoms rather than worsening them.

If you are taking metformin and getting up multiple times a night to urinate, the first thing to check is your blood sugar control. Elevated fasting glucose or high post-dinner spikes can drive nighttime urine production regardless of what medication you are on. Other common contributors include fluid intake close to bedtime, caffeine and alcohol consumption, and age-related changes in bladder capacity.

When Metformin Might Indirectly Affect Urinary Habits

Although metformin does not directly cause frequent urination, there are a few indirect routes worth knowing about. The most common side effects of metformin are gastrointestinal: diarrhea, nausea, and stomach upset, especially in the first few weeks. Some people respond to GI discomfort by drinking more water to stay hydrated or to settle their stomach, which naturally increases urine output. This is a behavioral change rather than a pharmacological effect of the drug, but it can feel like the medication is making you urinate more.

Another indirect pathway involves vitamin B12. Long-term metformin users have a meaningfully higher chance of developing B12 deficiency. A study of nearly 15,000 adults with type 2 diabetes found that long-term metformin users were about 67% more likely to be B12-deficient than non-users. Peripheral neuropathy, which involves nerve damage in the extremities, was about 39% more prevalent among long-term users compared to short-term users.¹¹ Nerve damage from either B12 deficiency or diabetic neuropathy can affect the nerves that control bladder sensation and emptying. When those nerves are impaired, the bladder may not empty completely, leading to a feeling of needing to go more often or difficulty sensing when the bladder is full until it is already overloaded. This is a long-term and indirect connection rather than a direct side effect, and it is preventable with B12 monitoring and supplementation.

Metformin and Prostate Enlargement

For men, one of the most common causes of urinary frequency in middle age and beyond is benign prostatic hyperplasia (BPH), where the prostate gland gradually enlarges and presses on the urethra. A nationwide population-based study in Korea examined whether metformin use in men with type 2 diabetes affected the progression of BPH. The study included over 211,000 patients sorted into groups based on whether they had diabetes and whether they used metformin.¹² The findings suggested a protective association, consistent with the Taiwanese study that found lower urinary symptom rates in long-term metformin users. If metformin slows prostate growth or reduces the inflammation that contributes to BPH, that would explain part of why men taking it seem to develop fewer urinary complaints.

The Gut Connection

Metformin is known to alter the composition of gut bacteria, and researchers have been working to understand what that means for the rest of the body. A randomized trial found that metformin increased levels of certain short-chain fatty acids, including acetate, butyrate, and valerate, at six months compared to a control group, although these changes did not persist at twelve months.¹³ Short-chain fatty acids have wide-ranging metabolic and anti-inflammatory effects, and shifts in the gut microbiome may partly explain metformin’s gastrointestinal side effects. Whether these microbial changes have any downstream effect on urinary function is unknown, but it is plausible that the diarrhea and fluid shifts that some people experience on metformin could temporarily influence how much and how often they urinate. This remains speculative, though, and no study has drawn a direct line from metformin’s microbiome effects to urinary frequency.

What to Do If You Are Urinating More on Metformin

If you have noticed increased urination since starting metformin, the most productive first step is checking your blood sugar records. If your glucose is still running high, the excess sugar in your blood is the likely driver, and better glycemic control should help. If your blood sugar is well managed and the problem persists, consider whether you recently started or adjusted any other diabetes medication, particularly an SGLT-2 inhibitor, which genuinely does increase urine output.

Other factors worth discussing with your doctor include:

Fluid intake: Are you drinking more water than usual to manage metformin-related GI symptoms or thirst from high blood sugar?
Caffeine and alcohol: Both are diuretics that can compound any existing tendency toward frequent urination.
Prostate health: For men over 50, BPH is common and often develops around the same age as type 2 diabetes.
Nerve function: If you have been on metformin for several years, ask about B12 levels and screening for peripheral neuropathy, which can affect bladder nerves.
UTI screening: A simple urinalysis can rule out infection as the cause of urgency and frequency.

Metformin’s well-documented side effects center on the gut, not the bladder. If urinary symptoms are your main complaint, the answer is almost certainly elsewhere, and the evidence increasingly suggests that metformin may be working in your favor when it comes to urinary health rather than against you.